The rise of superbacteria has rendered many antimicrobials useless while millions die. We develop next generation therapies.
Viosera Therapeutics made a Fast Pitch Presentation at the Oct. 6, 2017 MVF Business Builder Breakfast meeting. Viosera Therapeutics is developing a new therapy for Americans with MRSA bloodstream infections. These patients are in desperate need of new therapies that are less toxic and more effective.